Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Madagascar Periwinkle (Catharanthus roseus) produces over 130 terpenoid indole alkaloids—most notably vincristine and vinblastine—that bind tubulin proteins and arrest cancer cell mitosis, forming the basis of FDA-approved chemotherapy agents used against leukemia, lymphoma, and solid tumors (PMID 34562562). A 2023 systematic review confirmed the plant's additional hypoglycemic, antimicrobial, antioxidant, and neuroprotective activities, while vincamine, another key alkaloid, was shown to ameliorate diabetic peripheral neuropathy via GPR40 agonism in preclinical models (PMID 38651238; PMID 37580494).
Reported Benefits (Provisional)
Origin & History
Madagascar Periwinkle (Catharanthus roseus) is a flowering plant indigenous to Madagascar, now naturalized across tropical and subtropical regions worldwide. It thrives in well-drained soils under full sun exposure. This plant is highly valued in traditional medicine and modern pharmacology for its potent bioactive compounds.
Research Narrative (Provisional)
Kumar et al. (2022) published a comprehensive ethnopharmacological review in the Journal of Ethnopharmacology cataloging over 130 alkaloids from C. roseus and summarizing evidence for anticancer, antidiabetic, and antimicrobial activities (PMID 34562562). Xu et al. (2023) demonstrated in Acta Pharmacologica Sinica that vincamine acts as a GPR40 agonist, significantly ameliorating diabetic peripheral neuropathy in mouse models by improving nerve conduction velocity and reducing oxidative stress markers (PMID 37580494). Dubey et al. (2023) conducted a systematic review evaluating the pharmacological and phytochemical profiles of Madagascar periwinkle as a potential dietary supplement, confirming hypoglycemic, anti-inflammatory, and antioxidant bioactivities across multiple study designs (PMID 38651238). Shukla et al. (2024) reviewed vincristine-based nanoformulations in Drug Delivery and Translational Research, reporting improved bioavailability and reduced peripheral neuropathy side effects in preclinical and early clinical trials (PMID 37552393).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Alkaloids: Over 70 compounds including Vincristine, Vinblastine, Ajmalicine, Serpentine, Reserpine - Bioactives: Flavonoids, Saponins, Phenolic Compounds, Polyphenols, Phytosterols, Tannins - Vitamins: Vitamin C, Beta-carotene (Pro-Vitamin A) - Minerals: Potassium, Magnesium, Calcium
Reported Mechanism (Provisional)
The primary vinca alkaloids vincristine and vinblastine bind the β-tubulin subunit at the vinca domain, inhibiting tubulin polymerization and preventing mitotic spindle assembly, which arrests dividing cancer cells in metaphase (M-phase) and triggers caspase-dependent apoptosis (PMID 33390130). Vincamine, a distinct indole alkaloid from the same plant, functions as an agonist of G-protein-coupled receptor 40 (GPR40/FFAR1), activating downstream phospholipase C and calcium signaling pathways that enhance insulin secretion and protect peripheral nerves from diabetic neuropathy (PMID 37580494). Additional alkaloids including ajmalicine and serpentine exhibit α-adrenergic receptor antagonism, contributing to the plant's documented antihypertensive and vasodilatory effects. The monoterpene indole alkaloid biosynthetic pathway—fully elucidated through phytochemical genomics (PMID 25146650)—involves strictosidine synthase and multiple cytochrome P450 enzymes (CYP76A26, CYP71D12) that generate the diverse alkaloid scaffold responsible for these multi-target pharmacological activities.
Clinical Narrative (Provisional)
Extensive in vitro studies demonstrate potent cytotoxicity, with alkaloid fractions showing IC50 values of 10.9 ± 0.7 μg/mL against HeLa cancer cells. In vivo studies validate traditional hypoglycemic and antimicrobial uses, though specific clinical trial data with quantified outcomes remains limited. The vinca alkaloids vincristine and vinblastine are established FDA-approved chemotherapy agents, but controlled trials for other traditional uses lack published results. Research focuses primarily on preclinical efficacy rather than human clinical endpoints.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.